Benson Viscometers Ltd

Benson Viscometers is a world-leading manufacturer of clinical viscometers, trusted by hospitals, laboratories, universities and research institutions across the UK, USA, and Europe. Since 1999, they have provided reliable, high-precision clinical viscosity testing to support improved patient outcomes in conditions such as Multiple Myeloma, Waldenstrőm’s Macroglobulinaemia, Hyperviscosity Syndrome, Temporal Arteritis, Polymyalgia Rheumatica, Rheumatoid Arthritis, Cardiovascular Disease, COVID-19, Dementia and Vascular complications linked to Diabetes.

Inflammatory marker tests are commonly used in health care to detect infection and inflammation. The measurement of viscosity in blood plasma, serum, and whole blood is recognised as a rapid and reliable method. Although simple in application, viscosity testing demonstrates significant diagnostic potential, especially in the assessment and monitoring of complex conditions that are challenging to detect or measure.

Bensons Viscometers’ product range includes the BV1 Semi-Automated and BV200 Fully Automated Clinical Viscometers, both designed for precision, efficiency, and ease of use. Benson Viscometers are actively seeking to engage hospital and clinical laboratory procurement teams, develop partnerships with research and academic institutions for pilot studies, and collaborate with primary care networks to support GP education and raise awareness of viscosity testing.

With a long-standing commitment to clinical reliability and ISO-certified quality management systems, Benson Viscometers continues to expand internationally and aims to strengthen the adoption of viscosity testing in both clinical and research settings.